Bryce Murray, MD
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (59.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 91.1% of it on its own, with 26 other manufacturers making up the rest. Among surgery clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 249 payments — averaging $609.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$138K
- Johnson & Johnson$10K
- Boston Scientific$1K
- Medtronic$527
- Takeda Pharmaceuticals U.S.A., Inc.$299
- KCI USA, Inc.$250
- plus $1K from 21 others
What the payments were for
- Consulting fees$9,6426%
- Speaking & faculty fees$27,47518%
- Travel & lodging$15,59210%
- Food & beverage$7,9595%
- Education$90,85060%
- Gifts$2370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 163 | $138,236 |
| Johnson & Johnson | 8 | $9,878 |
| Boston Scientific | 6 | $1,200 |
| Medtronic(2 entities) | 8 | $527 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $299 |
| KCI USA, Inc. | 1 | $250 |
| AbbVie(2 entities) | 7 | $192 |
| Axonics, Inc. | 1 | $150 |
| Davol Inc. | 6 | $146 |
| Coloplast | 2 | $141 |
| Vertex | 1 | $123 |
| Ferring Pharmaceuticals Inc. | 7 | $111 |
| Baudax Bio Inc. | 4 | $69 |
| Polynovo North America LLC | 2 | $59 |
| Biom'up France SAS | 1 | $48 |
| Cook Medical LLC | 3 | $47 |
| Pacira Pharmaceuticals Incorporated | 2 | $38 |
| Shire North American Group Inc | 2 | $35 |
| Curium US LLC | 2 | $33 |
| Merck | 2 | $30 |
| Conmed Corporation | 1 | $25 |
| Acera Surgical, Inc. | 1 | $24 |
| Trevena, Inc. | 1 | $23 |
| W. L. Gore & Associates, Inc. | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $19 |
| Apollo Endosurgery US Inc | 1 | $19 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$132,314
- Monarch Platform$9,392
- DA VINCI SP$4,625
- GENERAL - THERAPIES$802
- MONARCH$486
- RESOLUTION CLIP$369
- INTERSTIM$293
- Axonics$150
- ALTIS$134
- JOURNAVX$123
How this compares
$151,755 in reported general payments places this provider in the 95th percentile of 290 surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 109 | $18,840 |
| CholestyramineCholestyramine (With Sugar) | 83 | $7,964 |
| MovantikNaloxegol Oxalate | 18 | $7,255 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 26 | $1,307 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 100 | $1,026 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 18 | $1,025 |
| Sucralfate | 20 | $954 |
| Neomycin Sulfate | 103 | $596 |
| Metronidazole | 131 | $381 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $341 |
| Chlorhexidine Gluconate | 93 | $337 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $178 |
| Tamsulosin Hcl | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ferring Pharmaceuticals Inc.Clenpiq | $111 | $18,840109 claims |
| Redhill Biopharma Inc.Movantik | $19 | $7,25518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 290 surgery providers in Oklahoma.
Other surgery in Tulsa
- Craig JohnsonTulsa$573K
- Eugene DickensTulsa$456K
- William JenningsTulsa$412K
- Steven FeherTulsa$50K
- Samuel PangburnTulsa$50K
- Jared LepleyTulsa$48K
- Ty KirkpatrickTulsa$28K
- John KingTulsa$24K
- Michael ThomasTulsa$22K
- Geoffrey ChowTulsa$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.